12:00 AM
May 20, 2013
 |  BC Week In Review  |  Financial News  |  Completed Offerings

ElsaLys Biotech completes venture financing

ElsaLys Biotech, Lyon, France
Business: Antibodies, Cancer, Inflammation

Read the full 25 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >